arrow
K

Kyung Hwa Park

chonnam national university
H指数:28
被引数:2,988

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, non-randomised extension of a phase 1/2 trial

GBP510重组蛋白纳米颗粒疫苗(一种SARS-CoV-2疫苗)与AS03佐剂同源加强针的安全性与免疫原性:一项期1/2临床试验开放标签非随机扩展研究的12个月随访结果

2025-10-080
OAAI
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10)

一项评估V116成人专用肺炎球菌疫苗相较于PPSV23,在≥50岁成人中安全性、耐受性和免疫原性的III期随机试验(STRIDE-10)

2025-03-220
OA
Comparison of clinical characteristics and outcomes in candidaemia patients with and without COVID-19: a multicentre retrospective study

有和没有新型冠状病毒肺炎的念珠菌血症患者的临床特征和结局的比较: 一项多中心回顾性研究

2024-12-280
OAAI
Prevalence and Associated Factors of Depression and Anxiety Among Healthcare Workers During the Coronavirus Disease 2019 Pandemic: A Nationwide Study in Korea

冠状病毒疾病2019大流行期间医护人员抑郁和焦虑的患病率及相关因素: 韩国的一项全国性研究

2024-01-011
OAAI
Ri sk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia

耐碳青霉烯类鲍曼不动杆菌菌血症患者早期死亡的相关因素分析

2022-12-0123
PRE
Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea, January-May 2020
2020-01-0158
OAAI